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Glomerulosclerosis and renal cysts in mice transgenic for the early
region of SV4O. Considerable evidence indicates that genetic determi-
nants play a major role in the pathogenesis of a variety of human and
experimentally-induced renal diseases. There are, however, no firm
data to indicate which genes or types of genes can induce or promote
renal disease. The recently acquired ability to make specific alterations
in the genetic background of an animal affords a unique opportunity to
assess the effect(s) of a given gene on the structure and function of an
organ of interest. Such modifications have been carried out in the
creation of transgenic mice. We examined mice transgenic for the
transforming gene encoding large T-antigen which is present in the early
region of simian virus 40 (SV4O). Renal lesions were present in most
animals. While there was some heterogeneity in the type and severity of
the renal lesions observed, a majority of the older mice displayed
glomerulosclerosis and/or proliferative tubular lesions which in some
were associated with multiple, large tubular cysts. The appearance of
these lesions in mice transgenic for a transforming gene suggests that
renal expression of a gene which controls cell proliferation may be
associated with the development of glomerulosclerosis and renal cysts.
These findings indicate a possible role for other transforming genes, or
oncogenes, in the pathogenesis of glomeruloscierosis and cystic renal
disease in humans and other animal models.
Data from a number of human diseases and animal models
suggest that genetic factors play a significant role in the patho-
genesis of, or susceptibility to, a variety of renal diseases.
Genetically determined factors play a role in the development
of polycystic kidney disease [1], Alport's disease [2], IgA
nephropathy [31, and have been more recently implicated in the
pathogenesis of focal segmental glomerulosclerosis [4—7].
The complexity of these diseases makes it extremely difficult
to determine which genetic elements are primarily responsible
for the development of renal disease. One approach to defining
which genes can promote a given disease by their expression or
overexpression is to create disease models in which the genetic
background of the animal is modified in a specific manner. Such
modifications have been successfully carried out in the creation
of transgenic mice [8]. Transgenic mice are made by microin-
jecting recombinant DNA into pronuclei of fertilized eggs. The
injected DNA is thought to randomly integrate at one site prior
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to cell division so that all of the embryo's cells carry the foreign
DNA [8].
In an attempt to analyze the role of oncogenes or transform-
ing genes in development and tumorigenesis, Brinster et al [9]
and Palmiter et al [10] established several lines of transgenic
mice by microinjecting DNA from the early region of simian
virus 40 (SV4O) which codes for the large and small T-antigens.
When constructs coding for large T-antigen along with its
72-base pair enhancers and 21-base pair repeats were used, the
mice appeared normal until approximately three to four months
of age, at which time choroid plexus tumors developed. Death
from these tumors typically occurred one to two weeks later. In
addition to the choroid plexus tumors, renal abnormalities were
found in the majority of animals. Thymic hyperplasia and
thymomas were observed occasionally and liver tumors were
encountered rarely. Immunoprecipitation with antibody against
large T-antigen revealed the presence of large T-antigen in
choroid plexus tumors, kidney, and thymus [9]. Unaffected
tissues (lung, intestine, muscle) did not have detectable amounts
of large T-antigen.
Previous publications involving these animals have focused
on the genetic elements responsible for the observed tissue
specific gene expression. Little attention has been devoted to
the types of renal lesions present in these mice. We report a
survey of microscopic findings in several lines of mice which
developed renal disease, and focus more specifically on one of
the lines which developed glomerular lesions similar to those
seen in human focal glomeruloscierosis.
Methods
Morphologic studies
Tissues for light microscopy were fixed in either 2.5% gluta-
raldehyde in cacodylate buffer or in 4%-neutral buffered forma-
un. Kidneys obtained from the SV Tag 188 construct were
embedded in methacrylate, cut into 2 t sections and stained
with H&E, PAS, and silver methenamine. Kidneys from other
lines were fixed in neutral buffered formalin, embedded in
paraffin, cut at 5 .t and stained with H&E, PAS and silver
methenamine.
Tissues from SV Tag 188 (8-1) mice which were 4 to 13 weeks
of age were examined by electron microscopy. Small pieces of
cortex were fixed in 3% glutaraldehyde buffered with 0.01 M
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cacodylate (pH 7.4) for 6 to 12 hours at 4°C. The fragments were
then washed extensively with the same buffer, post-fixed for
two hours in 2% osmium tetroxide, dehydrated in a series of
graded alcohols and embedded in Epon'. Thin sections con-
taining 3 to 6 glomeruli were chosen by examination of tolu-
idine-blue stained 1 p sections.
Kidneys for immunofluorescence microscopy were frozen in
liquid nitrogen, embedded in Histo PrepTM (Fisher Scientific,
Fair Lawn, New Jersey, USA), cut with a cryoslat at 4 to 5 ,
and the sections fixed for five minutes in acetone. Following a
five minute incubation in phosphate buffered saline (PBS), and
a 20 minute incubation in normal goat serum (Serotec, India-
napolis, Indiana, USA), the sections were incubated for 20
minutes with a 1:20 dilution of FITC conjugated, goat anti-
mouse IgG, 1gM (Tago, Burlingame, California, USA) or IgA
(Zymed, San Francisco, California, USA). Sections were washed
with PBS, mounted with several drops of a solution of 50 mg
p-phenylenediamine (Sigma, St. Louis, Missouri, USA), 5 ml
PBS, 45 ml glycerol (Sigma), and examined with a Leitz
microscope equipped with epifluorescence illumination.
Kidney sections used to detect T-antigen were cut at 8 p,
fixed for 10 minutes in acetone, rehydrated with PBS, pre-
incubated for 15 minutes with normal goat serum (Serotec) then
incubated for 20 minutes with a monoclonal antibody to large
T-antigen (diluted 1:5, final concentration 20 g/ml)(Oncogene,
Mineola, New York, USA). Sections were washed with PBS,
incubated with biotinylated goat, anti-mouse IgG for 20 minutes
(Tago), washed, then incubated with FITC conjugated avidin
(Zymed). The sections were then washed mounted and exam-
ined as above.
Screening for antibodies against glomerular antigens
Serum obtained from ether anesthetized transgenic animals
by cardiac puncture was applied (undiluted) to frozen sections
of normal, germ-free mouse kidney which were prepared, fixed,
and preincubated with normal goat serum as described above.
Sections were then washed in PBS and incubated with a 1:20
dilution of FITC conjugated goat anti-mouse IgG (Tago), fol-
lowing which the sections were washed, mounted, and exam-
ined as above.
Screening transgenic mouse serum for antibodies against
T-antigen
Baib 3T3 (ATCC CCL 163) and SV-T2 cells (ATCC CCL
163.1), an SV4O transformed Balb 3T3 cell line which was used
as a source of large T-antigen, were maintained in a defined
MEM/F12 medium [11, 12 as modified by P. Rabinovitch,
personal communication] supplemented with 10% fetal bovine
serum (Gibco, Grand Island, New York, USA). Near-confluent
cultures were washed with PBS, incubated with lysis buffer (150
mm NaCI, 50 mm Tris-HC1 pH 8.0, 5 mm EDTA, 0.5% NP4O,
100 pg/m1 PMSF, Sigma), harvested, and cleared by centrifu-
gation. Protein concentration was determined by the method of
Bradford [13] using an albumin standard and reagents from
Bio-Rad (Rockville Center, New York, USA). Lysate protein
concentration was adjusted to 50 ig/500 l of lysis buffer.
Lysates (500 d) were incubated with 1 jsg of a monoclonal
antibody to large T-antigen (Oncogene) then precipitated with
protein A-sepharose (Sigma) which was preswollen and washed
in PTA buffer (PBS, 0.5% Tween-20, 0.05% SDS, 0.1% bovine
serum albumin, 0.02% sodium azide). The beads were pelleted,
washed three times in PTA, then eluted by boiling for five
minutes in Laemmli sample buffer [14]. SDS gel electrophoresis
of samples and prestained, molecular weight markers were
performed by the method of Laemmli [141, using a 7.5% gel
which was then blotted to nitrocellulose as described [15].
The blots were washed in milk-NP4O buffer (MNP) containing
5% milk powder (Carnation, Los Angeles, California, USA) and
0.1% NP4O in PBS, then incubated with either antibody against
large T-antigen in MNP or with serum pooled from three, 4 or
10 week-old transgenic mice diluted 1:3 in MNP. Following
another series of washes in MNP the blots were incubated with 75
pg/ml goat anti-mouse IgG for one hour (Miles-Yeda, Napervifie,
Illinois, USA), washed in MNP, incubated with 50 p.g/ml mouse
peroxidase anti-peroxidase antibody (Jackson Immunoresearch,
Avondale, Pennsylvania, USA) for one hour, washed in MNP,
then washed in 0.5 M NaCl with 20 mm Tris-HC1 pH 7.5 (TBS).
Blots were developed by incubation in a freshly made solution
of 4-chloro- I -naphthol (Bio-Rad, Richmond, California, USA)
(60 mg in 20 ml cold methanol) mixed with 100 ml of TBS
containing 60 d of 30% H202.
Quantitation of glomerular number per kidney
Kidneys were removed from two 4 and two 7 week-old
transgenic animals and corresponding age-matched litter-mate
controls. Each kidney was processed separately using a modi-
fication of described procedures [16]. Briefly, the kidneys were
decapsulated, cut into 2 mm3 pieces, then incubated in 5 ml of
6 N HCL at 37°C for 90 minutes. Tissue fragments remaining
after this incubation were gently disrupted with a rubber
policeman. The suspension was diluted to a total volume of 30
ml with water, and the preparation allowed to sit at 4°C
overnight. The preparation was resuspended and a I ml aliquot
removed to a counting chamber (scored 35 mm culture dish).
The number of glomeruli ih the sample was counted under
phase microscopy. Each sample was counted in triplicate.
Triplicates generally agreed by 10%. The number of glomeruli
per kidney was determined by correcting the mean of the
glomerular counts for dilution and area of the chamber counted.
Determination of cardiac weight
Animals were weighed then sacrificed by cervical dislocation.
The heart and lungs were removed en bloc and the ventricles
dissected free of surrounding structures. The heart was weighed
after opening the ventricles and blotting it dry and free of clot.
Analysis of proteinuria
Random urine samples were obtained from 7, 11, and 15
week-old transgenic and litter-mate control mice which were
allowed free access to food and water. Protein was quantitated
as described above. Urine creatinine concentration was deter-
mined on an aliquot of the same sample using the Jaffe color-
imetric assay. Aliquots of urine containing 10 g of protein
were qualitatively analyzed using 10% SDS-PAGE and coomas-
sie blue staining as described [141.
Immunoprecipitation of T-antigen
The technique used was a modification of that described
above for screening transgenic mouse serum for antibodies
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Fig. 1. DNA constructs used in the creation of transgenic mice with
renal disease. Arrow in SV (CT) construct indicates site of point
mutation in gene encoding large T-antigen. Symbols are ( ) small
T-antigen; (R) large T-antigen.
against T-antigen. Briefly, cell and tissue homogenates which
were adjusted to a protein/volume of 5 mg/750 s1 of lysis buffer
were incubated with 1 p.g of monoclonal antibody to large T-
antigen (Oncogene), incubated with protein A-sepharose and
then centrifuged. Samples were subjected to elution, electro-
phoresis, and transfer to nitrocellulose as described above. The
nitrocellulose filter was washed, then the entire blot was
incubated in a first antibody solution containing 10 gIml of
monoclonal antibody against large T-antigen (Oncogene). Sub-
sequent incubations, washings and developing were performed
as detailed above.
Results
DNA constructs used to create the lines of mice which
developed renal disease are shown in Figure 1. Common to all
is the presence of the large T-antigen gene along with its 72 and
21 base-pair repeats. These repetitive segments have been
implicated in the efficient transcription of the large T-antigen
gene in vitro [17—191. Construct SV Tag 188 contains the coding
region for both large and small T-antigens, while construct
pSV-l 1 has a deletion in the region encoding small T-antigen.
The SV(cT) construct contains a point mutation in the coding
region for large T-antigen, which results in the substitution of
asparagine for lysine at amino acid number 128. This mutation
causes defective nuclear transport of large T-antigen [20] and
results in a cytoplasmic rather than nuclear localization of T-
antigen. In spite of this mutation, mice created using this
construct had lesions similar to that observed in mice created
using the SV Tag 188 and pSV 11 constructs [211. This corre-
sponds with in vitro data which demonstrate that nuclear
transport defective SV4O mutants retain the ability to transform
certain cell types t221.
Several lines of mice containing each DNA construct were
examined. A line consists of a founder mouse (which results
from the initial microinjection) and its foreign DNA inheriting
progeny. Each line would be expected to have a different
insertion site for the foreign DNA [81. Non-foreign DNA-
inheriting litter-mates from the SV Tag 188 8-1 line were used as
controls throughout these studies. Litter-mate control mice
were distinguished from transgenic mice by dot hybridization of
Glomerular
lesion
Line
Animal
#/sex
Age
wk
Syn/
MesScl Cres MesHC %Obs TPrf TDil
8-1 122/F 4 0 0 0 0 0 0
8-1 l52/M 5 ++ ++ + —c 0 0, casts
8-1 153/M 5 ++ + + —c o 0, casts
8-1 115/F 9 0 0 0 0 0 0
8-1 116/M 9 0 + 0 0 0 0
8-1 117/M 13 oa 0 0 0 0 0
8-1 118/F 13 + + 0 —c 0, casts
8-1 86/M 14 ++ + 0 —' + +
8-1 87/F 14 0 0 0 0 0 0
8-1 165/M 15 +++ ++ ++ —C
8-1 166/M 15 +++ ++ + c 0
8-1 l67/M 15 +++ ++ + —C 0
8-1 88/F 18 ++++ ++ 0 0 + 0, casts
8-1 96/M 20 + + + + 0 — 0 0, casts
8-1 97/M 20 +++ + + 0 0, casts
81-4 126/Mi' 14 + ++ 0 +++ ++++
84-3 124/Mb 8 + ++++ +++ 0 +++ ++++
85-2 125/Fb 8 +++ +++ 0 20 + +
2-1 98/Mb 72 oa 0 0 0 0 0
Founder animals were developed from C57B 1/6J X SJL/J F2 fertil-
ized eggs. Subsequent generations were derived by mating a transgenic
parent with control C57B1/6J X SJL/J Fl animals. A line includes a
founder mouse and any transgenic progeny.
Animal #, log accession number assigned each animal.
MesScl, mesangial sclerosis, scoring system: (+) affecting only few
glomeruli (<20%) and a small number of mesangial spaces; (+ +)
affecting more than 20% of glomeruli and a larger number of mesangial
spaces; (+ + +) diffuse with all mesangial spaces in all glomeruli
involved to a moderate degree; (+ + + +) diffuse with all mesangial
spaces in all glomeruli severely involved.
Syn/Cres, synechiae/crescents, scoring system: (+) present in less
than 10% of glomeruli; (+ +) present in 10—20% of glomeruli; (+ + +)
present in 20—50% of glomeruli; (+ + + +) present in over 50% of
glomeruli.
MesHc, mesangial hypercellularity, scoring system: (+) segmental
lesions with minimal amounts of proliferation; (+ +) diffuse lesions with
a moderate amount of proliferation.
%Obs, percentage obsolescent glomeruli.
TPI-f, tubular proliferation, scoring system: (+) segmental lesions
with modest amounts of proliferation; (+ +) segmental lesions with
more marked amount of proliferation; (+++) more diffuse lesions with
marked amounts of proliferation.
TDiI, tubular dilatation, scoring system: (+) segmental, minimal
dilatation; (+ +) segmental, modest dilatation; (+ + +) segmental,
marked dilatation; (+ + + +) diffuse dilatation with marked dilatation
with virtually no remaining normal tubules.
a thickened glomerular basement membrane
b founder animal
C fewer than fifty glomeruli in sample, no obsolescent glomeruli
genomic DNA (extracted from the distal portion of their tails) to
a SV4O early region DNA probe. We examined twenty-three,
3½- to 4-month old, litter-mate control animals. No renal
lesions were observed in any of the mice except for occasional
inflammatory cells in the interstitium of the juxtamedullary
areas.
Morphologic studies
SV Tag 188. Mice from five different lines were examined.
Details of individual animals are given in Table 1. The most
consistently observed lesions were those of increased mesan-
SV4O Early region
Kpn1 BamHl
188 h-i
Table 1. Construct: SV Tag 188
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Fig. 2. Glomerulus with a moderate increase in the amount of mesangial matrix and mild hypercellularily in 4-week-old mouse. (PAS X790)
Fig. 3. Mesangial hypertrophy with small synechia (arrow) in 13-week-old mouse. (Epon embedded, 1 micron section, toluidine-blue x316)
Fig. 4. Focal sclerosis with a large synechia (arrow) and prominent Bowman's cells in 13-week-old mouse. (Epon embedded, 1 micron section,
toluidine-blue x 316)
Fig. S. Focal sclerosis—characteristic segmental glomerular lesion—in 12-week-old mouse. Apparent hypercellularity of the juxtaglomerular
apparatus was present in both the transgenic and control animals. (PAS x 198)
Fig. 6. Massive tubular dilatation and
atrophy with multiple tubular cysts in 8
week-old mouse. (Hematoxylin-eosin X 100)
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Table 2. Construct: PSV 11
Glomerular
lesion
Animal Age Syn/
Line #/sex wk MesScl Cres MesHC %Obs TPrf TDil
38-7 90/M 20 02 0 + 0 + 0
118-1 131/Mb 24 0 0 0 0 0 0
118-3 135/M 5 ++ ++ 0 10 0 0
118-3 2117/Mb 8 ++++ +++ 0 80 0 ++++
118-3 2150/F 8 ++++ +++ ++ 30 0 ++,casts
118-3 2151/F 8 ++ +++ + 50 + ++, casts
118-3 132/M 12 d ++ + 0 0 0
118-3 133/F 12 + ++ + 20 ++ +
118-3 134/F 12 ++ +++ + 10 + +
118-3 136/M 12 o' 0 0 0 + 0
118-3 137/F 12 ++ +++ + 10 ++ 0
118-3 138/M 12 ++ +++ + 10 + 0
gial matrix, focal glomeruloscierosis, and tubular epithelial cell
proliferation. Two animals (81-4 [#1261, 84-3 [#1241) had marked
tubular cell proliferation with cystic-appearing tubular lesions.
In the younger animals from the 8-1 line the glomerular
lesions consisted of a minimal to marked increase in the amount
of mesangial matrix in a small portion of glomeruli (Fig. 2) with
occasional sclerotic glomeruli. Older animals showed mesangial
hypercellularity (Fig. 3) and focal segmental glomerular sclero-
sis (Fig. 4 and 5). No tumors were noted, but there often was
localized, tubular epithelial cell proliferation in older animals.
In several animals there were groups of tubules with atrophied
epithelium containing occasional proteinaceous casts both in
cortical and medullary regions.
Mice #126 and #124 had nearly identical tubular lesions,
consisting of epithelial cell proliferation with massive cystic
dilatation, which was reminiscent of the lesions seen in poly-
cystic kidney disease (Fig. 6). Focal glomeruloscierosis and few
synechiae were noted in the glomeruli of #126 while glomeruli
in #124 showed proliferative glomerular lesions with crescents.
PSV 11. Three different lines were available for evaluation
(Table 2). Mouse #90 (line 38-7) had large but otherwise normal
glomeruli and only focal-tubular epithelial cell proliferation,
while mouse #131 from line 118-1 had a normal kidney. Several
mice were available from line 118-3. Two different types of
histologic lesions were observed in these animals.
The first pattern present in animals #132 to 138 consisted of
mild focal and segmental glomerular lesions. In all kidneys the
size of the glomerular tuft was variable. The affected glomeruli
were not localized to any particular area of the kidney. The
obsolescent glomeruli were atrophic with a reduction in the
number of nuclei. An increase in mesangial matrix was noted in
the non-obsolescent glomeruli. In some glomeruli the sclerotic
area was segmental and was connected to the thickened Bow-
man's capsule through a large synechia. In a few glomeruli
there were amorphous PAS-positive deposits resembling the
areas of focal sclerosis described in human focal glomerulo-
sclerosis. A few atrophic tubules were observed. Tubular
epithelial proliferation was common, but focal. Mice #133 and
#134 showed focal tubular dilatation in addition to tubular cell
Glomerular
lesion
Line
Animal
#/sex
Age
wk
Syn!
MesScl Cres MesHC %Obs TPrf TDiI
268-5 139/Fe' 5 + + ++ 5 ++ ++
268-3 140/Fb +++ ++ + 50 ++ +++
269-5 14l/Fb 7 + ++ + 0 + 0
274-2 142/Mb 7 ++ + + 0 + 0
269-1 143/F" 12 +++ +++ + 0 + 0
274-4 89/Fb 20 + + + + + 0 90 + + oe
274-4 93/M 12 O 0 0 0 + 0
274-7 1b 5 + 0 0 0 + 0
274-7 145/F 16 ++++ ++++ 0 90 + +, casts
proliferation. The interstitium contained a small number of
inflammatory cells, generally around the damaged tubules.
The second pattern of abnormalities was observed in animals
#2117, 2150, and 2151. Glomerular lesions in these animals
were much more severe. Most glomeruli appeared sclerotic
without a marked proliferative component. The glomerular tuft
was contracted and replaced by connective tissue. Massive
acellular synechiae were observed. The tubules were dilated; in
some instances the dilated lumina were huge, cyst-like, and
filled with proteinaceous casts. In a number of tubules the
epithelium had marked proliferative activity with multilayers of
cells bearing large dark nuclei (Fig. 7). The interstitium con-
tained disseminated infiltrates of plasma cells and lymphocytes.
The arteries and arterioles were unremarkable.
SV (cT). Kidneys from nine animals representing seven
different lines were examined (Table 3). The lesions observed
consisted primarily of sclerotic glomerular lesions associated
with varying degrees of tubular epithelial cell proliferation.
In animals #139, 141, 142, 143, and 144 the glomerular and
tubular lesions were very mild with occasional obsolescent
glomeruli. Most glomerular tufts showed only segmental lesions
Refer to Table 1 legend for abbreviations and scoring systems.d Large glomeruli Fig. 7. Tubular epithelial cell proliferation with occasional hyper-
chromatic nuclei in 12-week-old mouse. (Hematoxylin-eosin x312)
Table 3. Construct: SV (cT)
Refer to legend for Table 1.
C Epithelial cell tumor invading renal medulla
Irregular glomerular basement membrane
C'
 
TransgenicAge
wk IgG 1gM IgA IgG
Normal
1gM IgA
Animals raised in a conventional environment
4 tr 3+ 1+ tr 1+ neg
tr 2+ 3+
10 tr 3+ 4+ neg 3+ 1+
2+ 3+ 1+
12 1+ 3+ 2+ 1+ 2+ tr
Animals raised in a germ-free environment
12 2+ 3+ neg neg 3+ neg
3+ 4+ neg tr 3+ neg
4+ 3+ neg neg 3+ neg
which consisted of a moderate increase in mesangial matrix,
which was sometimes associated with minimal increase in the
number of nuclei. Synechiae were observed in a small number
of glomeruli. Focal areas of tubular proliferation were noted.
Occasional tubules had an atrophic epithelium, a thickened
basement membrane and contained casts. The arteries and
interstitium appeared normal.
Three animals had end-stage renal disease but with different
patterns. In #140 massive tubular atrophy was the most con-
spicuous feature, with flattened epithelium and large dilated
lumina. The glomeruli were atrophic with approximately 50% of
them appearing obsolescent and containing large synechiae.
Mouse #89 presented an unusual glomerulosclerosis: 100% of
the glomeruli were massively enlarged showing an accentuation
of the normal lobulation which was reminiscent of human
membranoproliferative glomerulonephritis; however, the num-
ber of remaining glomerular cells did not appear to be in-
creased. The increase in extracellular matrix appeared to be
mainly mesangial without crescents or synechiae. In this animal
most of the tubules were atrophied. Those tubules without
atrophy had a moderate amount of proliferation. This mouse
also had a renal tumor composed of epithelial cells which
invaded the renal medulla. In mouse #145 the end-stage gb-
merular lesions appeared different. The glomeruli showed dif-
fuse sclerosis without proliferation, large synechiae and hyalin-
Fig. 9. Western blot of SV-T2 immunoprecipitate (lanes B, D, F, H)
and 3T3 immunoprecipitate (lanes C, F, G, I) incubated with 100 nglml
monoclonal antibody against large T-antigen (lanes B, C), 4-week-old
transgenic mouse serum (lanes D, E), 10-week-old transgenic mouse
serum (lanes F, G), or no first antibody (lanes H, I). Large T-antigen
(mol wt 93,000) is detected by monoclonal antibody in lane B. Open
arrow indicates location of heavy chain of mouse antibody to large
T-antigen used for immunoprecipitation. Closed arrows indicate loca-
tion of molecular weight markers of 116,000, 92,500, 66,000, and 45,000
daltons in lanes A and J.
like deposits (Fig. 8). Most glomeruli were massively involved
but a nodular accentuation of the lesions was not present. Most
tubules had a flattened atrophic epithelium and contained hyalin
casts. The arteries appeared normal.
Electron microscopy (SV Tag 188 8-1 line)
The principal feature revealed by electron microscopy, which
confirmed the light microscopic findings, was the presence of a
diffuse increase in the amount of mesangial matrix. This change
was most obvious at 10 weeks of age and progressively wors-
ened in older animals. Distinct, electron-dense deposits were
not identified either in the matrix or within the cells of the
mesangium, suggesting that the immunoglobulins identified by
immunofluorescence were diffusely distributed rather than pre-
sent as aggregates such as might be expected in the case of
antigen-antibody complexes.
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Fig. 8. End-stage scierosing lesion with complete obliteration of the
glomerular tuft in 16-week-old mouse. (Hematoxylin-eosin x312)
Table 4. Glomerular immunoglobulin deposits
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Table 5. Glomerular number
Age
wk
Transgenic Normal
Righta Left Total Right Left Total
4 4955
5821
4983
5888
9938
11709
6310
6465
5866
5866
11043
12331
8 8599
5399
7999
7043
16596
12442
4954
6244
5184
6599
10820
12843
Abbreviations are: right, number of glomeruli in right kidney; left,
number of glomeruli in left kidney; and total, sum of glomerular number
in right and left kidney.
a Number of glomeruli in each kidney was determined by counting
the number of glomeruli in an aliquot of an HCI digested kidney. The
mean of triplicate counts was corrected for dilution and area of counting
chamber evaluated to yield the total number of glomeruli per kidney.
Transgenic Normal
Age U, Ur Up Ucr
wk jhg/ml Up/Ur g/ml Up/Ucr
7 330
390
860
320
330
650
1.0
1.2
1.3
420
620
470
800
0.9
0.8
11 310
530
470
290
550
500
1.1
1,0
0.9
150
210
340
310
460
560
0.5
0.5
0.6
15 3040
8200
2240
370
700
580
8.2
11.7
3.9
560
320
740
430
0.8
0.7
Abbreviations are: Ui,, urinary protein and UCr, urinary creatinine.
Table 6. Cardiac/Total body weight
Age
wk
Transgenic Normal
Total Card Ratio Total Card Ratio
4 15.6
17.9
71
80
4.6
4.5
21.1
21.6
94
101
4.5
4.7
7 19.4
19.3
20.0
103
83
83
5.3
4.3
4.2
22.6
23.4
22.3
20.6
106
110
106
108
4.7
4.7
4.8
5.2
10 22.3
19.0
18.5
111
92
86
5.0
4.8
4.6
22.8
25.5
27.6
110
120
132
4.8
4.7
4.8
Abbreviations are: total, total body weight (g); card, cardiac weight
(mg); and ratio, cardiac weight (mg)/total body weight (g).
A B C D E G H I
The epithelial cells showed no lesions. Of note is the fact that
spreading of the pedicels was absent at all time points except in
areas of obvious synechiae where overall glomerular architec-
ture was significantly altered.
Immunofluorescence microscopy (SV Tag 188 8-1 line)
The findings of immunofluorescence staining for IgG, 1gM,
and IgA of transgenic and control mice are given in Table 4.
Based on these results we were uncertain if the presence of
immunoglobulins in the glomeruli reflected a pathogenic proc-
ess mediated by deposition of antibodies or whether their
presence reflected trapping in the glomerulus as is commonly
found in normal mice raised in a non-germ-free environment
[231.
Three transgenic and three, normal litter-mate mice which
were hysterectomy-derived and raised in a germ-free environ-
ment displayed no immunofluorescence staining for IgA, but
did have staining for 1gM (Table 4). Transgenic mice also
displayed immunofluorescence staining for IgG. Two of the
three transgenic mice raised in a germ-free environment showed
moderate focal glomerular lesions comparable to those ob-
served in non-germ-free transgenic mice of the SV Tag 188 8-1
line. Germ-free litter-mate controls had no glomerular lesions
by light microscopy.
Antibody screening (SV Tag 188 8-1 line)
In order to further define the role of the glomerular IgG
deposits we screened serum from transgenic mice for the
Fig. 10. SDS-PAGE of urine from transgenic mice. Lane B: Control
mouse serum. Lanes C, D: 15 week-old animals. Lanes E, F: 11
week-old animals. Lanes G, H: 7 week-old animals. Lanes A, I:
Molecular weight markers of 116,000, 92,000, 66,000, and 45,000
daltons indicated by arrows.
presence of antibodies to glomerular antigens. Because large
T-antigen had been demonstrated to be present in the kidney,
we also specifically sought the presence of circulating antibod-
ies against large T-antigen.
Sera from three 7, 11, and 15 week-old transgenic mice were
screened for the presence of anti-glomerular antibodies by
indirect immunofluorescence. Frozen sections of kidney from a
normal germ-free mouse served as target tissue. Eight of the
serum samples had no reactivity with the kidney sections. The
ninth, from a 7-week-old mouse, had antinuclear antibodies
present at a titer of less than 1:20.
Sera from transgenic mice were evaluated for the presence of
antibodies against large T-antigen by incubating them with a
preparation of large T-antigen which had been purified from cell
lysates of SV4O transformed Baib 3T3 cells (SV-T2) by immu-
noprecipitation with a monoclonal antibody against large T-
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Fig. 11. Frozen section of kidney from a 7 week-old transgenic mouse stained with a monoclonal antibody against T-antigen. The nuclei in the
control animal sections and in the majority of the section in the transgenic animals (A) appear as dark "holes" against a background of faint
cytoplasmic staining. In contrast, nuclei in the T-antigen positive areas (B) evidence the patchy nuclear staining typical of T-antigen positive cells.
Note the normal cellularity and diameter of the non-T-antigen expressing tubules (A) while the T-antigen expressing tubule(s) (B) appear
hypercellular (proliferative) and dilated. (x316)
antigen, electrophoresis (SDS-PAGE), and blotting to nitrocel-
lulose. Following serum incubation, blots were incubated in
series with goat anti-mouse IgG, mouse peroxidase anti-perox-
idase, and finally developed in 4-chloro-1-naphthol and H202
(Fig. 9). Despite the sensitivity of this technique which gave a
strong signal with 100 ng/ml of antibody against T-antigen
(which represents approximately 0.00 1% of normal mouse IgG)
the serum samples from transgenic mice had no evidence of
antibody against large T-antigen.
Quantitation of glomerular number (SV Tag 188 8-1 line)
The possibility that the transgenic mice had a reduced num-
ber of glomeruli per kidney which could lead to hyperfiltration
and glomerulosclerosis was evaluated. Glomerular counts were
determined for each kidney from two 4-week-old and two
8-week-old transgenic mice and control animals of correspond-
ing ages. As shown in Table 5 the number of glomeruli in
transgenic animals did not differ significantly from that of
control animals (P > 0.50, Student's t-test).
Hypertension
Because of the difficulties involved in obtaining accurate
blood pressure measurements in young mice (weight generally
<20 to 25 g) we searched instead for evidence of end organ
damage which would suggest that hypertension was responsible
in whole or in part for the observed glomerular lesions. A
careful review of renal sections from the transgenic and normal
animals failed to reveal any arterial-arteriolar lesions, even in
the mice with the more severe renal lesions. The sclerotic
glomeruli were large and did not show atrophy of the tuft or
wrinkling of the glomerular basement membrane as is typical
for hypertension-induced glomerular lesions.
Comparison of cardiac/total body weight ratios did not reveal
evidence of the cardiac hypertrophy which would be expected
in an animal with hypertension of sufficient severity to induce
hypertensive renal disease (Table 6). For comparison purposes
it should be noted that spontaneously hypertensive rats have a
greater than 10% increase in their cardiac/total body weights by
the age of 5 weeks [24].
Proteinuria
Because accurate, timed urine collections are difficult to
obtain from mice we evaluated proteinuria by determining the
urinary protein/creatinine ratio on untimed urine samples [25].
Results are given in Table 7. In transgenic mice proteinuria
increased with age. The 15 week-old mice had proteinuria in
marked excess of that detected in younger animals. In addition
to the control animals listed in Table 7 we evaluated sixteen 3V2-
to 4-month-old control animals. The Up/Uc ratio was 1.0 or less
in all of these control animals (range 0.4 to 1.0, mean 0.70).
The urinary protein was qualitatively analyzed by SDS-
PAGE as shown in Figure 10. Fifteen week old mice had high
molecular weight, non-selective proteinuria as demonstrated by
the similar pattern of protein distribution in normal mouse
serum in lane B and the urine samples in lanes C and D.
Detection of T-antigen in kidneys of transgenic mice
(SV Tag 188 8-1 line)
T-antigen was detected by immunofluorescence staining of
frozen sections and by immunoprecipitation of homogenates of
whole kidney. Immunofluorescence staining with antibody to
T-antigen revealed nests of T-antigen positive cells in what
appeared to be proliferating tubules (Fig. 11). The presence of
IgG deposits in the glomeruli of the transgenic mice made it
difficult to assess the presence or absence of T-antigen positive
cells within the glomerulus.
Immunoprecipitation of a homogenate of a glomerular cell
line derived from SV Tag 188 8-1 animals (manuscript submit-
ted) with a monoclonal antibody against T-antigen revealed a
doublet at the expected location of T-antigen (mol wt 93,000).
Similar doublet bands have been noted in other cells expressing
T-antigen [26]. Immunoprecipitation of choroid-plexus tumor
homogenate from a 4-month-old animal revealed the same
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H J While factors such as gene copy number, insertion site, or
variability in genetic background (animals created in a C57B l/6J
X SJL/J background) may play a role in dictating the severity of
the lesions, the development of glomerular and tubular lesions
in several different lines of mice created with different DNA
constructs suggests that these factors do not play an essential
role in dictating the development of the observed renal lesions.
Tubular lesions in these animals consisted of varying degrees
of tubular epithelial cell proliferation which was associated with
moderate to severe (cystic) dilatation in some animals. Alter-
ations in proliferative potential evidenced by decreased dou-
bling time, lack of contact inhibition of growth, and infinite life
span are the most commonly observed phenotypic alterations in
cells transfected in vitro with SV4O [27—29]. The finding of large
T-antigen in whole kidney homogenates, the proliferative na-
türe of the majority of the observed tubular lesions, and the
demonstration of T-antigen staining in a proliferative, dilated
tubular lesion suggest that these lesions are induced by local
production of large T-antigen. Since large T-antigen expression,
and expression of other oncogenes in vitro has been shown to
cause abnormalities in the synthesis of collagen and proteogly-
cans, it is possible that abnormalities in these components may
also contribute to the development the tubular lesions [30—33].
Glomerular lesions in the transgenic mice appeared to in-
crease in severity with age. Progressive impairment of glomer-
ular function was demonstrated by the presence of increasing
proteinuria with age. The relationship between the glomerular
lesions and renal large T-antigen expression is less clear than
for the tubular lesions because we were not able to clearly
demonstrate the production of T-antigen by glomerular cells in
vivo. For this reason it was necessary to carefully examine the
possibility that extrarenal factors existed which could induce
glomerulosclerosis. There was no correlation between the rarely
occurring extrarenal pathology (grossly evident thymomas,
hepatic tumors) and the renal lesions. Choroid plexus tumors
and more severe renal disease appeared to be associated in that
both occurred in the three to four month-old animals. The
young age of the animals, the absence of intrarenal vascular
damage suggestive of hypertension, and the absence of cardiac
hypertrophy combine to make hypertension an unlikely cause
of the glomerular lesions. Repeated screening of urine for
glycosuria was negative indicating that diabetes mellitus was
not responsible for the lesions. A diminished number of neph-
rons was not responsible as the transgenic and normal animals
had equivalent numbers of glomeruli. An immune-mediated
mechanism was suggested by the presence of glomerular IgG in
germ-free transgenic mice but not normal litter-mates. While
the absence of circulating antiglomerular antibodies and anti-
bodies against large T-antigen speak against an immune medi-
ated etiology it remains a possibility that these antibodies were
present at levels below the sensitivity of the assays employed.
However, the finding of glomerular immunoglobulin deposits in
this model is consistent with the finding of glomerular immuno-
globulins in other models of glomerulosclerosis, including par-
tial nephrectomy and diabetic nephropathy, which are presum-
ably not immunologically mediated [34—36].
If extrarenal factors are not responsible for the genesis of
these lesions it is possible that, like the tubular lesions, the
glomerular lesions developed because of alterations in glomer-
ular cell behavior induced by expression of the transforming
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Fig. 12. immunoprecipitate of cell or tissue homogenates from trans-
genic and control animals with a monoclonal antibody to T-antigen.
Lane A: Glomerular cell line derived from kidneys of SV Tag 188 8-1
animals which is strongly positive on immunofluorescence staining for
T-antigen in vitro. Lane Th The same cell line without addition of
antibody to T-antigen for immunoprecipitation. Lane C: Brain from
4-month-old transgenic animal without grossly evident tumor. Lane D:
Choroid plexus tumor from 4 month-old transgenic animal. Lane E:
Kidney from 4 week-old transgenic animal. Lane F: Kidney from a
second 4 week-old transgenic animal. Lane G: Kidney from 4-week-old
control animal. Lane H: Brain from 4 week-old transgenic animal. Lane
I: Brain from second 4 week-old transgenic animal. Lane J: Brain from
4 week-old control animal. Arrows indicate location of molecular
weight markers of 92,500, 66,000, and 45,000 daltons.
doublet and a fainter band of slightly lower molecular weight.
Immunoprecipitation of kidney homogenates from two 4 week-
old transgenic animals revealed a pattern corresponding to the
two lower, molecular weight bands seen in the choroid plexus
tumor. In contrast, no bands were seen with immunoprecipita-
tion of a homogenate from the kidney of a 4 week-old litter-mate
control mouse or from whole brain homogenates of the two 4
week-old transgenic mice and the control animal (Fig. 12).
The ability to manipulate the genetic background of an animal
in a specific manner affords a unique opportunity to assess the
effect of a given gene on the growth and development of an
animal and also to evaluate the effect of that gene on the
structure and function of organs in which it is expressed.
Given the demonstrated ability of SV4O early region gene-
products, specifically large T-antigen, to effect a malignant
transformation of cells in vitro [27—291 it is not surprising that
tumors developed in organs which produced large T-antigen in
vivo (choroid plexus, thymus, liver) [9, 10]. Interestingly how-
ever, the presence of large T-antigen protein in the kidney was
only rarely associated with the development of renal tumors.
Instead, the majority of transgenic animals we examined had
proliferative tubular lesions and/or sclerotic glomerular lesions.
Discussion
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gene encoding large T-antigen within the kidney or within the
glomerulus itself. The presence of glomerular lesions in these
animals raises the possibility that dysregulation of genes which
normally control glomerular cell proliferation might play a role
in the pathogenesis of glomeruloscierosis. The hypertrophy and
hyperplasia observed in partial nephrectomy models of glomer-
ulosclerosis and in diabetic nephropathy suggest a role for
dysregulation of glomerular cell growth in the pathogenesis of
glomerulosclerosis [37—39]. It is also possible that other mole-
cules such as collagen, proteoglycans, and platelet-derived growth
factor whose production is altered in vitro by large T-antigen
expression may play a role in the development of glomerulo-
sclerosis in this model [30—33,40].
In summary, mice transgenic for the early region of SV40
develop a variety of renal lesions, the most consistently ob-
served of which are proliferative, sometimes multicystic, tubu-
lar lesions and glomeruloscierosis. The presence of these le-
sions in mice with renal expression of the transforming gene,
large T-antigen suggests that dysregulation of genes which
control glomerular and tubular cell proliferation may play a role
in the pathogenesis of both cystic renal diseases and gk meru-
losclerosis.
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